Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
ABBOTT LABORATORIES incurred revolving credit of up to $5 billion with JPMorgan Chase Bank, N.A. at SOFR rate, plus an applicable margin maturing fifth anniversary of the Effective Date.
- Instrument
- revolving credit
- Principal
- up to $5 billion
- Counterparty
- JPMorgan Chase Bank, N.A.
- Rate
- SOFR rate, plus an applicable margin
- Maturity
- fifth anniversary of the Effective Date
- Event
- incurrence
Exact text from the filing
lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent. The Revolving Credit Agreement provides Abbott with the ability to borrow up to $5 billion on an unsecured basis. Any borrowings under the Revolving Credit Agreement will mature and be payable on the fifth anniversary of the Effective Date. As of the date of this
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
ABBOTT LABORATORIES entered into Five Year Credit Agreement with JPMorgan Chase Bank, N.A. valued at $5 billion unsecured borrowing capacity (effective 2024-01-29).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- JPMorgan Chase Bank, N.A.
- Value
- $5 billion unsecured borrowing capacity
- Effective
- 2024-01-29
Exact text from the filing
On January 29, 2024 (the “ Effective Date ”), Abbott Laboratories, an Illinois corporation (“ Abbott ”), entered into a Five Year Credit Agreement (the “ Revolving Credit Agreement ”) with the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
ABBOTT LABORATORIES terminated Five Year Credit Agreement, dated as of November 12, 2020 with JPMorgan Chase Bank, N.A. valued at Terminated all commitments; no outstanding borrowings (effective 2024-01-29).
- Action
- termination
- Agreement
- credit facility
- Counterparty
- JPMorgan Chase Bank, N.A.
- Value
- Terminated all commitments; no outstanding borrowings
- Effective
- 2024-01-29
Exact text from the filing
In connection with its entry into the Revolving Credit Agreement, on the Effective Date Abbott terminated all commitments outstanding under the Five Year Credit Agreement, dated as of November 12, 2020 (as amended by that certain Amendment No. 1, dated as of May 12, 2023, the “ Existing Credit Agreement ”), among Abbott, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent.
View on SEC.gov